Feghali Maisa N, Mattison Donald R
Department of Obstetrics and Gynecology, Washington Hospital Center, Washington, DC 20010, USA.
J Biomed Biotechnol. 2011;2011:783528. doi: 10.1155/2011/783528. Epub 2011 Jul 6.
Most drugs are not tested for use during pregnancy, consequently, labeling, which may include information about fetal safety, includes nothing about dosing, efficacy, or maternal safety. Yet these are concerns of health care providers considering treatment of disease during pregnancy. Therefore, the practitioner treats the pregnant woman with the same dose recommended for use in adults (typically men) or may decide not to treat the disease at all. However, is the choice of not treating a woman during pregnancy better than dealing with the challenges which accompany treatment? This paper, which summarizes metabolic and physiologic changes induced by pregnancy, illustrates that standard adult dosing is likely to be incorrect during pregnancy.
大多数药物未在孕期进行使用测试,因此,药品标签(其中可能包含有关胎儿安全性的信息)未提及任何关于给药剂量、疗效或母体安全性的内容。然而,这些都是医疗保健人员在考虑孕期疾病治疗时所关心的问题。所以,从业者会按照推荐给成年人(通常为男性)使用的相同剂量来治疗孕妇,或者可能干脆决定不对疾病进行治疗。但是,在孕期不治疗女性的选择是否比应对治疗带来的挑战更好呢?本文总结了孕期引起的代谢和生理变化,表明孕期使用标准成人剂量很可能是不正确的。